# Nodexus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nodexus

- Industry: Biotechnology
- Headquarters: Berkeley, US
- Website: www.nodexus.com/
- Total disclosed funding: $30M
- Latest round: Series A (Dec 16, 2021)
- Investors on record: 2

## About

Nodexus Inc. specializes in advanced cell sorting technology, focusing on innovative systems that facilitate gentle cell sorting and dispensing for biological research applications.Nodexus Inc. was founded in 2014 in Berkeley, US to develop advanced cell sorting and dispensing systems. The company has not pivoted in its core business strategy and operates without subsidiaries. It was co-founded by Karthik Balakrishnan and Vincent Tuminelli, with Karthik Balakrishnan serving as the CEO. In December 2021, Nodexus raised USD 30 mn in Series A funding, led by RA Capital with participation from Section 32, bringing the total amount raised to USD 30 mn.Nodexus specializes in advanced cell sorting and dispensing systems, primarily focusing on the NX One and NX One MAX platforms. These systems utilize microfluidic technology designed for gentle cell sorting and single-cell dispensing, catering to disease research and drug discovery. Target customers include biotech and pharmaceutical companies, and academic research institutions, with a global market presence in North America, Europe, and Asia.Nodexus generates revenue through the sale of its NX One and NX One MAX cell sorting systems, along with associated microfluidic cartridges. The transaction structure is primarily B2B, engaging directly with research institutions and laboratories. The core systems are priced under USD 100,000, supplemented by consumable cartridges that require periodic replacement, ensuring ongoing revenue streams.Following its recent funding of USD 30 mn in December 2021, Nodexus plans to significantly expand its team to further its mission of democratizing biological tools. The company is focused on launching new products and expanding into new markets, although specific new product launches and targeted regions have not been detailed. The funds raised will be utilized to support these initiatives, enhancing their operational capacity and market reach.

## Funding rounds

- Series A, Dec 16, 2021, $30M — RA Capital Management, Section 32

## Investors

- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series A
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series A